October 31, 2008 |
WoundStat™ Marketer TramaCure, Inc. Wins 2008 Small Business Award
Montgomery County honored TramaCure this morning with its 2008 Small Business Award at the annual Workforce and Economic Development Awards Breakfast at the Marriott-Bethesda North Hotel and Conference Center ... Read more
|
October 29, 2008 |
U.S. Military Deploying TramaCure’s WoundStat™ Troops to Get World’s Most Effective Hemostatic Agent
The U.S. Army has placed a major order for WoundStat™, a powerful agent for controlling arterial bleeding, TramaCure announced today ... Read more
|
September 22, 2008 |
TraumaCure Receives CE Mark Clearance to Sell WoundStat in Europe
TramaCure Inc. today announced that its ground-breaking hemostatic agent, WoundStat™, has received CE Mark approval, clearing the way for sales in the European Union and all countries recognizing the CE Mark. CE Mark approval from the European Union certifies WoundStat™ has met health, safety and environmental requirements for consumer safety ... Read more
|
September 16, 2008 |
TraumaCure Receives Health Canada Licensure for New Hemostatic Agent that Stops Major Bleeding in Seconds
TramaCure Inc. today announced that Health Canada has issued a medical device license for WoundStat™, a ground-breaking hemostatic agent for control of bleeding in high-pressure arterial wounds ... Read more
|
August 13, 2008 |
WoundStat™ Inventors Recognized for Their Outstanding Medical Research Contributions to Combat Casualty Care
Virginia Commonwealth University (VCU) researchers Kevin Ward, MD, Robert Diegelmann, PhD, and Gary Bowlin, PhD, this week received the Award for Excellence in recognition of their outstanding contributions to combat casualty care from the US Army Medical Research and Materiel Command, Combat Casualty Care Research Program ...
Read more
|
June 23, 2008 |
TraumaCure Receives Prestigious ISO 13485 Certification
TramaCure Inc.- makers of the groundbreaking hemostatic agent, WoundStat™ - today announced that the company has received the prestigious international ISO 13485 certification for its quality system for design, development, production and sales of medical devices. The company received FDA clearance to sell WoundStat™ in August 2007 ... Read more
|
June 3, 2008 |
US Department of Defense Recommends Soldiers Carry WoundStat™ for Life-Threatening Bleeding
US Military Finds WoundStat™ the Most Effective Hemostatic Agent Available - TraumaCure Inc. announced today that the DOD Joint Committee on Tactical Combat Casualty Care (CoTCCC) has recommended that U.S. soldiers from all services carry the company’s hemostatic agent, WoundStat™ ... Read more
|
March 11, 2008 |
U.S. Army Study Reports WoundStat™ is Most Effective
The U.S. Army Institute of Surgical Research (ISR), the world’s premier ballistic injury research facility, today issued the results of a study showing that TraumaCure’s ground-breaking WoundStat™ is the most effective wound treatment available to stop severe bleeding—the number one cause of death for soldiers in battle. Only WoundStat™ was 100 percent effective at stopping high-pressure arterial bleeding in severe wounds ...
Read more
|
September 10, 2007 |
Life-saving News for Battlefield Soldiers & Wounded Civilians
A lightweight, pre-mixed, dressing compound that is scientifically-proven to stem high-pressure bleeding in moderate to severe wounds has received FDA ...
Read more |
